Scientists discover antibodies that may protect against COVID-19
In a new study, researchers found that COVID specific IgA monoclonal antibodies may provide effective immunity in the respiratory system against the novel coronavirus—a...
Too much fruit sugar in meals may cause a leaky gut, fatty liver disease
In a new study, researchers found excessive consumption of fructose—a sweetener ubiquitous in the American diet—can result in non-alcoholic fatty liver disease (NAFLD), which...
Scientists find new way to predict who will get severe COVID-19 and die
In a new study, researchers have identified two markers of inflammation that reliably predict the severity of COVID-19 cases and the likelihood of survival.
The...
Intensive weight loss may reduce obesity-related cancer risk
In a new study, researchers found that an intensive lifestyle intervention aimed at weight loss lowered the risk of obesity-related cancers in people with...
COVID-19 in wastewater can be infectious, study shows
In a new study, researchers found wastewater containing the COVID-19 virus may be a serious threat.
The research was conducted by a team from the...
How to treat the most common heart attacks
One in five patients die within a year after the most common type of heart attack.
In a new paper, researchers provide new treatment guidelines...
This test method could find COVID-19 carriers with no symptoms
In a new study, researchers confirm the success of a new COVID-19 pooling test that identifies all positive people, including asymptomatic carriers, in a...
This popular high blood pressure drug may cause harmful side effects
Chlorthalidone is the guideline-recommended diuretic drug for lowering blood pressure.
But a recent study from Columbia University Irving Medical Center showed that this drug could...
Early immune response may contribute to severe COVID-19, study shows
In a new study, researchers may have come one step closer toward understanding how the immune system contributes to severe COVID-19.
They found that so-called...
This common type 2 diabetes drug may increase heart failure risk
In a recent study from Yale School of Public Health and elsewhere, researchers found new evidence that type 2 diabetes drug rosiglitazone is linked...